Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals. (Q51039642)

27 March 2018

title

Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals. (English)

1 reference

27 March 2018

author name string

S Dimonte

1

1 reference

27 March 2018

M Babakir-Mina

2

1 reference

27 March 2018

S Aquaro

3

1 reference

27 March 2018

C-F Perno

4

1 reference

27 March 2018

publication date

26 April 2013

1 reference

27 March 2018

published in

Infection

1 reference

27 March 2018

volume

41

1 reference

27 March 2018

issue

6

1 reference

27 March 2018

page(s)

1097-1102

1 reference

27 March 2018

Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Resistance to HIV-1 integrase inhibitors: A structural perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Authentic HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

HIV type 1 integrase polymorphisms in treatment-naive and treatment-experienced HIV type 1-infected patients in Thailand where HIV type 1 subtype A/E predominates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Natural polymorphisms of integrase among HIV type 1-infected South African patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

The future of integrase inhibitors of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0464-5

Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance

21 January 2018

1 reference

12 December 2020

A cutting-edge view on the current state of antiviral drug development

1 reference

12 December 2020

2011 update of the drug resistance mutations in HIV-1.

1 reference

12 December 2020

Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication

1 reference

12 December 2020

Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes

1 reference

12 December 2020

10.1007/S15010-013-0464-5

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018